T

he pharmaceutical industry is playing an intensifying game of whack-a-mole as its latest battle over a so-called drug take-back program is being fought in Washington state, which could become the third state in the nation to force drug makers to finance collections of unused or unwanted medicines.

The Washington bill, which was first introduced a year ago, is now gaining momentum in the state House of Representatives, where a vote may occur this week, according to legislators and lobbyists. And the lawmaker who sponsored the bill believes the state Senate will be amenable to the legislation, as well.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Big pharma loves to conjure up scary stories of what might happen if we implement drug takeback programs. But there’s no need to guess. Santa Cruz County has had the country’s most comprehensive takeback program since 2006. Every pharmacy in the county collects drugs, as well as sharps, for proper disposal at no cost. And there has been zero diversion. No thefts, no spills, no problems of any kind. The program works great, and has been a boon for local citizens and the environment. And it costs next to nothing! This is the reality, and it’s time we implemented it everywhere.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy